Centene Corp. (CNC)

$66.39

-1.81

(-2.65%)

Market is closed - opens 7 PM, 20 Jun 2024

Insights on Centene Corp.

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 37.60B → 40.40B (in $), with an average increase of 2.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 45.0M → 1.16B (in $), with an average increase of 96.1% per quarter

  • Vs CI

    In the last 1 year, The Cigna Corp has given 24.5% return, outperforming this stock by 23.4%

  • Vs CI

    In the last 3 years, The Cigna Corp has given 44.3% return, outperforming this stock by 51.7%

Performance

  • $66.05
    $68.72
    $66.39
    downward going graph

    0.51%

    Downside

    Day's Volatility :3.88%

    Upside

    3.39%

    downward going graph
  • $60.83
    $81.42
    $66.39
    downward going graph

    8.37%

    Downside

    52 Weeks Volatility :25.29%

    Upside

    18.46%

    downward going graph

Returns

PeriodCentene Corp.Sector (Health Care)S&P500
3 Months
-15.64%
0.1%
6.7%
6 Months
-10.92%
8.3%
15.1%
1 Year
0.71%
10.4%
24.4%
3 Years
-8.01%
17.9%
31.7%

Highlights

Market Capitalization
36.4B
Book Value
$50.26
Earnings Per Share (EPS)
5.07
PE Ratio
13.45
PEG Ratio
0.68
Wall Street Target Price
88.49
Profit Margin
1.92%
Operating Margin TTM
4.39%
Return On Assets TTM
3.67%
Return On Equity TTM
10.44%
Revenue TTM
142.8B
Revenue Per Share TTM
264.74
Quarterly Revenue Growth YOY
4.3999999999999995%
Gross Profit TTM
24.5B
EBITDA
6.1B
Diluted Eps TTM
5.07
Quarterly Earnings Growth YOY
0.06
EPS Estimate Current Year
6.85
EPS Estimate Next Year
7.6
EPS Estimate Current Quarter
2.08
EPS Estimate Next Quarter
1.98

Analyst Recommendation

Buy
    56%Buy
    43%Hold
    0
    0%Sell
Based on 23 Wall street analysts offering stock ratings for Centene Corp.(by analysts ranked 0 to 5 stars)
Based on 23 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
13
13
Hold
10
10
9
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 33.29%

Current $66.39
Target $88.49

Company Financials

FY18Y/Y Change
Revenue
60.1B
↑ 24.25%
Net Income
900.0M
↑ 8.7%
Net Profit Margin
1.5%
↓ 0.21%
FY19Y/Y Change
Revenue
74.6B
↑ 24.16%
Net Income
1.3B
↑ 46.78%
Net Profit Margin
1.77%
↑ 0.27%
FY20Y/Y Change
Revenue
111.1B
↑ 48.87%
Net Income
1.8B
↑ 36.87%
Net Profit Margin
1.63%
↓ 0.14%
FY21Y/Y Change
Revenue
126.0B
↑ 13.38%
Net Income
1.3B
↓ 25.5%
Net Profit Margin
1.07%
↓ 0.56%
FY22Y/Y Change
Revenue
144.5B
↑ 14.74%
Net Income
1.2B
↓ 10.76%
Net Profit Margin
0.83%
↓ 0.24%
FY23Y/Y Change
Revenue
154.0B
↑ 6.54%
Net Income
2.7B
↑ 124.79%
Net Profit Margin
1.75%
↑ 0.92%
Q4 FY22Q/Q Change
Revenue
35.6B
↓ 0.85%
Net Income
-219.0M
↓ 129.67%
Net Profit Margin
-0.62%
↓ 2.68%
Q1 FY23Q/Q Change
Revenue
38.9B
↑ 9.36%
Net Income
1.1B
↓ 615.98%
Net Profit Margin
2.91%
↑ 3.53%
Q2 FY23Q/Q Change
Revenue
37.6B
↓ 3.29%
Net Income
1.1B
↓ 6.37%
Net Profit Margin
2.81%
↓ 0.1%
Q3 FY23Q/Q Change
Revenue
38.0B
↑ 1.15%
Net Income
469.0M
↓ 55.67%
Net Profit Margin
1.23%
↓ 1.58%
Q4 FY23Q/Q Change
Revenue
39.5B
↑ 3.73%
Net Income
45.0M
↓ 90.41%
Net Profit Margin
0.11%
↓ 1.12%
Q1 FY24Q/Q Change
Revenue
40.4B
↑ 2.4%
Net Income
1.2B
↑ 2484.44%
Net Profit Margin
2.88%
↑ 2.77%
FY18Y/Y Change
Total Assets
30.9B
↑ 41.39%
Total Liabilities
19.9B
↑ 32.71%
FY19Y/Y Change
Total Assets
41.0B
↑ 32.66%
Total Liabilities
28.3B
↑ 42.38%
FY20Y/Y Change
Total Assets
68.7B
↑ 67.63%
Total Liabilities
42.8B
↑ 51.07%
FY21Y/Y Change
Total Assets
78.4B
↑ 14.05%
Total Liabilities
51.4B
↑ 20.1%
FY22Y/Y Change
Total Assets
76.9B
↓ 1.92%
Total Liabilities
52.6B
↑ 2.49%
FY23Y/Y Change
Total Assets
84.6B
↑ 10.11%
Total Liabilities
58.7B
↑ 11.5%
Q4 FY22Q/Q Change
Total Assets
76.9B
↓ 5.3%
Total Liabilities
52.6B
↓ 5.29%
Q1 FY23Q/Q Change
Total Assets
83.0B
↑ 7.95%
Total Liabilities
57.8B
↑ 9.81%
Q2 FY23Q/Q Change
Total Assets
82.9B
↓ 0.16%
Total Liabilities
57.1B
↓ 1.26%
Q3 FY23Q/Q Change
Total Assets
84.4B
↑ 1.84%
Total Liabilities
59.0B
↑ 3.33%
Q4 FY23Q/Q Change
Total Assets
84.6B
↑ 0.31%
Total Liabilities
58.7B
↓ 0.47%
Q1 FY24Q/Q Change
Total Assets
82.6B
↓ 2.38%
Total Liabilities
55.6B
↓ 5.33%
FY18Y/Y Change
Operating Cash Flow
1.2B
↓ 17.13%
Investing Cash Flow
-4.6B
↑ 262.45%
Financing Cash Flow
4.6B
↓ 5724.39%
FY19Y/Y Change
Operating Cash Flow
1.5B
↑ 20.18%
Investing Cash Flow
-1.5B
↓ 66.59%
Financing Cash Flow
6.8B
↑ 48.14%
FY20Y/Y Change
Operating Cash Flow
5.5B
↑ 271.07%
Investing Cash Flow
-7.0B
↑ 353.98%
Financing Cash Flow
260.0M
↓ 96.19%
FY21Y/Y Change
Operating Cash Flow
4.2B
↓ 23.59%
Investing Cash Flow
-3.3B
↓ 52.57%
Financing Cash Flow
1.4B
↑ 423.85%
FY22Y/Y Change
Operating Cash Flow
6.3B
↑ 48.89%
Investing Cash Flow
-2.9B
↓ 11.46%
Financing Cash Flow
-4.2B
↓ 408.15%
Q4 FY22Q/Q Change
Operating Cash Flow
-1.6B
↓ 147.3%
Investing Cash Flow
-2.9B
↓ 97466.67%
Financing Cash Flow
-1.7B
↑ 16.95%
Q1 FY23Q/Q Change
Operating Cash Flow
4.3B
↓ 370.88%
Investing Cash Flow
-253.0M
↓ 91.34%
Financing Cash Flow
-183.0M
↓ 89.43%
Q2 FY23Q/Q Change
Operating Cash Flow
2.5B
↓ 40.36%
Investing Cash Flow
-424.0M
↑ 67.59%
Financing Cash Flow
-750.0M
↑ 309.84%
Q3 FY23Q/Q Change
Operating Cash Flow
1.0B
↓ 59.9%
Investing Cash Flow
-242.0M
↓ 42.92%
Financing Cash Flow
-524.0M
↓ 30.13%

Technicals Summary

Sell

Neutral

Buy

Centene Corp. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Centene Corp.
Centene Corp.
-14.41%
-10.92%
0.71%
-8.01%
19.71%
The Cigna Corp
The Cigna Corp
0.43%
13.75%
23.98%
41.58%
108.99%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
-6.99%
-8.2%
2.48%
20.85%
92.27%
Cvs Health Corporation
Cvs Health Corporation
6.29%
-20.0%
-11.15%
-27.39%
11.15%
Humana Inc.
Humana Inc.
-1.6%
-24.6%
-21.75%
-19.75%
36.12%
Elevance Health, Inc
Elevance Health, Inc
-2.64%
13.21%
20.41%
40.09%
81.16%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Centene Corp.
Centene Corp.
13.45
13.45
0.68
6.85
0.1
0.04
NA
50.26
The Cigna Corp
The Cigna Corp
27.39
27.39
0.89
28.52
0.09
0.03
0.02
144.9
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
30.39
30.39
1.24
27.61
0.17
0.07
0.02
94.23
Cvs Health Corporation
Cvs Health Corporation
10.56
10.56
1.0
7.03
0.1
0.03
0.04
59.08
Humana Inc.
Humana Inc.
22.13
22.13
1.64
16.34
0.12
0.05
0.01
133.86
Elevance Health, Inc
Elevance Health, Inc
20.16
20.16
1.14
37.28
0.16
0.06
0.01
174.62
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Centene Corp.
Centene Corp.
Buy
$36.4B
19.71%
13.45
1.92%
The Cigna Corp
The Cigna Corp
Buy
$94.9B
108.99%
27.39
1.77%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$457.5B
92.27%
30.39
4.05%
Cvs Health Corporation
Cvs Health Corporation
Buy
$75.6B
11.15%
10.56
2.04%
Humana Inc.
Humana Inc.
Buy
$43.3B
36.12%
22.13
1.82%
Elevance Health, Inc
Elevance Health, Inc
Buy
$124.3B
81.16%
20.16
3.64%

Institutional Holdings

  • Vanguard Group Inc

    11.42%
  • BlackRock Inc

    7.92%
  • FMR Inc

    7.49%
  • Capital World Investors

    5.05%
  • State Street Corporation

    4.39%
  • Wellington Management Company LLP

    3.71%

Company Information

centene corporation, a fortune 500 company, is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. many receive benefits provided under medicaid, including the state children's health insurance program (chip), as well as aged, blind or disabled (abd), foster care and long term care (ltc), in addition to other state-sponsored/hybrid programs, and medicare (special needs plans). the company operates local health plans and offers a range of health insurance solutions. it also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health management, care management software, correctional healthcare services, dental benefits management, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services.

Organization
Centene Corp.
Employees
59900
CEO
Ms. Sarah M. London
Industry
Health Services

FAQs